Astrazeneca Plc stock is traded at $186.76, with a volume of 1,803,197. It is down -1.39% in the last 24 hours and up +17.31% over the past month. A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Previous Close:
$189.39
Open:
$186.71
24h Volume:
1,803,197
Relative Volume:
0.53
Market Cap:
$289.65B
Revenue:
$60.48B
Net Income/Loss:
$10.40B
P/E Ratio:
56.09
EPS:
$3.33
Net Cash Flow:
$8.05B
1W Performance:
-1.19%
1M Performance:
+17.31%
6M Performance:
+2.69%
1Y Performance:
+4.82%
1-Day Range:
$184.96$188.10
1-Week Range:
$181.20$192.65
52-Week Range:
$153.41$212.71
Astrazeneca Plc Stock (AZN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS